Literature DB >> 17123731

Spinal NK-1 receptor expressing neurons mediate opioid-induced hyperalgesia and antinociceptive tolerance via activation of descending pathways.

Louis P Vera-Portocarrero1, En-Tan Zhang, Tamara King, Michael H Ossipov, Todd W Vanderah, Josephine Lai, Frank Porreca.   

Abstract

Opioids can induce hyperalgesia in humans and in animals. Mechanisms of opiate-induced hyperalgesia and possibly of spinal antinociceptive tolerance may be linked to pronociceptive adaptations occurring at multiple levels of the nervous system including activation of descending facilitatory influences from the brainstem, spinal neuroplasticity, and changes in primary afferent fibers. Here, the role of NK-1 receptor expressing cells in the spinal dorsal horn in morphine-induced hyperalgesia and spinal antinociceptive tolerance was assessed by ablating these cells with intrathecal injection of SP-saporin (SP-SAP). Ablation of NK-1 receptor expressing cells prevented (a) morphine-induced thermal and mechanical hypersensitivity, (b) increased touch-evoked spinal FOS expression, (c) upregulation of spinal dynorphin content and (d) the rightward displacement of the spinal morphine antinociceptive dose-response curve (i.e., tolerance). Morphine-induced hyperalgesia and antinociceptive tolerance were also blocked by spinal administration of ondansetron, a serotonergic receptor antagonist. Thus, NK-1 receptor expressing neurons play a critical role in sustained morphine-induced neuroplastic changes which underlie spinal excitability reflected as thermal and tactile hypersensitivity to peripheral stimuli, and to reduced antinociceptive actions of spinal morphine (i.e., antinociceptive tolerance). Ablation of these cells likely eliminates the ascending limb of a spinal-bulbospinal loop that engages descending facilitation and elicits subsequent spinal neuroplasticity. The data may provide a basis for understanding mechanisms of prolonged pain which can occur in the absence of tissue injury.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17123731      PMCID: PMC4028682          DOI: 10.1016/j.pain.2006.09.033

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  66 in total

1.  Selective innervation of lamina I projection neurones that possess the neurokinin 1 receptor by serotonin-containing axons in the rat spinal cord.

Authors:  E Polgár; Z Puskár; C Watt; C Matesz; A J Todd
Journal:  Neuroscience       Date:  2002       Impact factor: 3.590

Review 2.  Opioid-induced hyperalgesia: a qualitative systematic review.

Authors:  Martin S Angst; J David Clark
Journal:  Anesthesiology       Date:  2006-03       Impact factor: 7.892

3.  Neurokinin-1 receptors on lumbar spinothalamic neurons in the rat.

Authors:  G E Marshall; S A Shehab; R C Spike; A J Todd
Journal:  Neuroscience       Date:  1996-05       Impact factor: 3.590

Review 4.  Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions.

Authors:  Jianren Mao; Donald D Price; David J Mayer
Journal:  Pain       Date:  1995-09       Impact factor: 6.961

5.  Transmission of chronic nociception by spinal neurons expressing the substance P receptor.

Authors:  M L Nichols; B J Allen; S D Rogers; J R Ghilardi; P Honore; N M Luger; M P Finke; J Li; D A Lappi; D A Simone; P W Mantyh
Journal:  Science       Date:  1999-11-19       Impact factor: 47.728

6.  Projection neurons in lamina I of rat spinal cord with the neurokinin 1 receptor are selectively innervated by substance p-containing afferents and respond to noxious stimulation.

Authors:  Andrew J Todd; Zita Puskar; Rosemary C Spike; Catriona Hughes; Christine Watt; Lisa Forrest
Journal:  J Neurosci       Date:  2002-05-15       Impact factor: 6.167

7.  Basal and touch-evoked fos-like immunoreactivity during experimental inflammation in the rat.

Authors:  Q P Ma; C J Woolf
Journal:  Pain       Date:  1996-10       Impact factor: 6.961

8.  Descending facilitation from the rostral ventromedial medulla maintains nerve injury-induced central sensitization.

Authors:  L P Vera-Portocarrero; E-T Zhang; M H Ossipov; J Y Xie; T King; J Lai; F Porreca
Journal:  Neuroscience       Date:  2006-05-02       Impact factor: 3.590

9.  Time-dependent descending facilitation from the rostral ventromedial medulla maintains, but does not initiate, neuropathic pain.

Authors:  Shannon E Burgess; Luis R Gardell; Michael H Ossipov; T Philip Malan; Todd W Vanderah; Josephine Lai; Frank Porreca
Journal:  J Neurosci       Date:  2002-06-15       Impact factor: 6.167

10.  A calcitonin gene-related peptide receptor antagonist prevents the development of tolerance to spinal morphine analgesia.

Authors:  D P Menard; D van Rossum; S Kar; S St Pierre; M Sutak; K Jhamandas; R Quirion
Journal:  J Neurosci       Date:  1996-04-01       Impact factor: 6.167

View more
  37 in total

Review 1.  Roles of reactive oxygen and nitrogen species in pain.

Authors:  Daniela Salvemini; Joshua W Little; Timothy Doyle; William L Neumann
Journal:  Free Radic Biol Med       Date:  2011-01-28       Impact factor: 7.376

2.  Tachykinin NK₁ receptor antagonist co-administration attenuates opioid withdrawal-mediated spinal microglia and astrocyte activation.

Authors:  Suneeta Tumati; Tally M Largent-Milnes; Attila I Keresztes; Takashi Yamamoto; Todd W Vanderah; William R Roeske; Victor J Hruby; Eva V Varga
Journal:  Eur J Pharmacol       Date:  2012-06-05       Impact factor: 4.432

3.  Spinal or systemic TY005, a peptidic opioid agonist/neurokinin 1 antagonist, attenuates pain with reduced tolerance.

Authors:  T M Largent-Milnes; T Yamamoto; P Nair; J W Moulton; V J Hruby; J Lai; F Porreca; T W Vanderah
Journal:  Br J Pharmacol       Date:  2010-11       Impact factor: 8.739

4.  Spinal mediators that may contribute selectively to antinociceptive tolerance but not other effects of morphine as revealed by deletion of GluR5.

Authors:  A M Gregus; C N Inra; T P Giordano; A C S Costa; A M Rajadhyaksha; C E Inturrisi
Journal:  Neuroscience       Date:  2010-03-29       Impact factor: 3.590

5.  Descending facilitation maintains long-term spontaneous neuropathic pain.

Authors:  Ruizhong Wang; Tamara King; Milena De Felice; Wenhong Guo; Michael H Ossipov; Frank Porreca
Journal:  J Pain       Date:  2013-04-19       Impact factor: 5.820

6.  The Effect of Ondansetron on Acute Opioid Tolerance in Patients Receiving Intrathecal Opioids Prior to Cesarean Delivery.

Authors:  Kevin C Greer; Abdullah S Terkawi; Siny Tsang; Priyanka Singla; Marcel E Durieux; Mohamed Tiouririne
Journal:  Reg Anesth Pain Med       Date:  2017 Sep/Oct       Impact factor: 6.288

7.  Preprotachykinin-A gene disruption attenuates nociceptive sensitivity after opioid administration and incision by peripheral and spinal mechanisms in mice.

Authors:  Peyman Sahbaie; Xiaoyou Shi; Xiangqi Li; Deyong Liang; Tian-Zhi Guo; Yanli Qiao; David C Yeomans; Wade S Kingery; J David Clark
Journal:  J Pain       Date:  2012-10       Impact factor: 5.820

8.  NADPH-oxidase 2 activation promotes opioid-induced antinociceptive tolerance in mice.

Authors:  T Doyle; E Esposito; L Bryant; S Cuzzocrea; D Salvemini
Journal:  Neuroscience       Date:  2013-02-27       Impact factor: 3.590

9.  From mouse to man: the 5-HT3 receptor modulates physical dependence on opioid narcotics.

Authors:  Larry F Chu; De-Yong Liang; Xiangqi Li; Peyman Sahbaie; Nicole D'arcy; Guochun Liao; Gary Peltz; J David Clark
Journal:  Pharmacogenet Genomics       Date:  2009-03       Impact factor: 2.089

Review 10.  Preclinical and early clinical investigations related to monoaminergic pain modulation.

Authors:  Kirsty Bannister; Lucy A Bee; Anthony H Dickenson
Journal:  Neurotherapeutics       Date:  2009-10       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.